Bio Works (Sweden) Market Value
| BIOWKS Stock | SEK 1.45 0.10 6.45% |
| Symbol | Bio |
Bio Works 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Bio Works' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Bio Works.
| 12/18/2024 |
| 03/18/2025 |
If you would invest 0.00 in Bio Works on December 18, 2024 and sell it all today you would earn a total of 0.00 from holding Bio Works Technologies AB or generate 0.0% return on investment in Bio Works over 90 days. Bio Works is related to or competes with Genovis AB, Cantargia, Intervacc, C Rad, and Xbrane Biopharma. Bio-Works Technologies AB researches, develops, manufactures, and supplies agarose based resins used to separate protein... More
Bio Works Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Bio Works' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Bio Works Technologies AB upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.61 | |||
| Information Ratio | 0.24 | |||
| Maximum Drawdown | 29.79 | |||
| Value At Risk | (6.45) | |||
| Potential Upside | 11.65 |
Bio Works Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bio Works' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Bio Works' standard deviation. In reality, there are many statistical measures that can use Bio Works historical prices to predict the future Bio Works' volatility.| Risk Adjusted Performance | 0.2056 | |||
| Jensen Alpha | 1.25 | |||
| Total Risk Alpha | 1.72 | |||
| Sortino Ratio | 0.2744 | |||
| Treynor Ratio | 1.38 |
Bio Works Technologies Backtested Returns
Bio Works is dangerous given 3 months investment horizon. Bio Works Technologies secures Sharpe Ratio (or Efficiency) of 0.22, which signifies that the company had a 0.22 % return per unit of risk over the last 3 months. We were able to break down and interpolate data for thirty different technical indicators, which can help you to evaluate if expected returns of 1.19% are justified by taking the suggested risk. Use Bio Works Downside Deviation of 4.61, mean deviation of 3.89, and Risk Adjusted Performance of 0.2056 to evaluate company specific risk that cannot be diversified away. Bio Works holds a performance score of 17 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 0.85, which signifies possible diversification benefits within a given portfolio. Bio Works returns are very sensitive to returns on the market. As the market goes up or down, Bio Works is expected to follow. Use Bio Works semi variance, and the relationship between the treynor ratio and daily balance of power , to analyze future returns on Bio Works.
Auto-correlation | 0.75 |
Good predictability
Bio Works Technologies AB has good predictability. Overlapping area represents the amount of predictability between Bio Works time series from 18th of December 2024 to 1st of February 2025 and 1st of February 2025 to 18th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Bio Works Technologies price movement. The serial correlation of 0.75 indicates that around 75.0% of current Bio Works price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.75 | |
| Spearman Rank Test | 0.77 | |
| Residual Average | 0.0 | |
| Price Variance | 0.03 |
Bio Works Technologies lagged returns against current returns
Autocorrelation, which is Bio Works stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Bio Works' stock expected returns. We can calculate the autocorrelation of Bio Works returns to help us make a trade decision. For example, suppose you find that Bio Works has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Bio Works regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Bio Works stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Bio Works stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Bio Works stock over time.
Current vs Lagged Prices |
| Timeline |
Bio Works Lagged Returns
When evaluating Bio Works' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Bio Works stock have on its future price. Bio Works autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Bio Works autocorrelation shows the relationship between Bio Works stock current value and its past values and can show if there is a momentum factor associated with investing in Bio Works Technologies AB.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in Bio Stock
Bio Works financial ratios help investors to determine whether Bio Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bio with respect to the benefits of owning Bio Works security.